BURLINGTON, Mass., Oct. 4, 2022 /CNW/ -- MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that its Life Science business sector has opened a commercial facility for its new Millipore® CTDMO Services offering at the company's site in Martillac, France. The 2,700-square-meter facility will provide global supply of commercial drug substances, including mAbs and other recombinant proteins, from an integrated site featuring state-of-the-art single-use equipment and onsite regulatory, quality and technical experts.
Read more at newswire.caMilliporeSigma Announces a Boost in Commercial Capacity in France as Part of New Millipore® CTDMO Services
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here